Last reviewed · How we verify

NCT06140004

Home-Based Palliative Care Impact on Providers

Completed Last updated 22 November 2023
What this trial tests

trial in Palliative Care in 24 participants. Completed in 31 October 2020.

Timeline
15 September 2016
Primary endpoint
27 June 2019
31 October 2020

Quick facts

Lead sponsorUniversity of Southern California
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date15 September 2016
Primary completion27 June 2019
Estimated completion31 October 2020
Sites3 locations across United States

Conditions studied

Sponsor

University of Southern California

Who can join

18 and older, any sex, with Palliative Care or Health Personnel. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research challenges our current approach to fee-for-service palliative care and is significant because it will advance the fields of palliative and person-centered care, clinical practice, public policy, and health care financing. However, the most important effect will be on seriously ill patients and their families through increased access to palliative care outside of hospitals, enhanced palliative continuity across health settings, and improved affordability via reformed payment structures. Nation-wide replication of reimbursable HBCP models is anticipated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06140004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing